nodes	percent_of_prediction	percent_of_DWPC	metapath
Sildenafil—CYP1A1—polycystic ovary syndrome	0.558	1	CbGaD
Sildenafil—PDE5A—clitoris—polycystic ovary syndrome	0.0557	0.383	CbGeAlD
Sildenafil—Angina unstable—Metformin—polycystic ovary syndrome	0.0104	0.0839	CcSEcCtD
Sildenafil—Viral diarrhoea—Metformin—polycystic ovary syndrome	0.0101	0.0812	CcSEcCtD
Sildenafil—CYP2C19—urine—polycystic ovary syndrome	0.00554	0.0381	CbGeAlD
Sildenafil—Sinus congestion—Metformin—polycystic ovary syndrome	0.00529	0.0426	CcSEcCtD
Sildenafil—PDE6G—adrenal gland—polycystic ovary syndrome	0.00508	0.0349	CbGeAlD
Sildenafil—PDE6H—endocrine gland—polycystic ovary syndrome	0.00458	0.0315	CbGeAlD
Sildenafil—CYP2C9—urine—polycystic ovary syndrome	0.00429	0.0295	CbGeAlD
Sildenafil—CYP2E1—urine—polycystic ovary syndrome	0.00407	0.028	CbGeAlD
Sildenafil—Nail disorder—Metformin—polycystic ovary syndrome	0.00406	0.0327	CcSEcCtD
Sildenafil—CYP3A4—urine—polycystic ovary syndrome	0.00327	0.0225	CbGeAlD
Sildenafil—Rhinorrhoea—Metformin—polycystic ovary syndrome	0.00325	0.0262	CcSEcCtD
Sildenafil—CYP2D6—urine—polycystic ovary syndrome	0.00322	0.0221	CbGeAlD
Sildenafil—Contusion—Metformin—polycystic ovary syndrome	0.00302	0.0243	CcSEcCtD
Sildenafil—Accidental injury—Metformin—polycystic ovary syndrome	0.00297	0.024	CcSEcCtD
Sildenafil—Neuropathy—Metformin—polycystic ovary syndrome	0.00247	0.0199	CcSEcCtD
Sildenafil—Ear pain—Metformin—polycystic ovary syndrome	0.00224	0.018	CcSEcCtD
Sildenafil—PDE5A—adipose tissue—polycystic ovary syndrome	0.00224	0.0154	CbGeAlD
Sildenafil—ADORA2A—adrenal gland—polycystic ovary syndrome	0.0022	0.0152	CbGeAlD
Sildenafil—ABCC10—adrenal cortex—polycystic ovary syndrome	0.00213	0.0146	CbGeAlD
Sildenafil—Nasal congestion—Metformin—polycystic ovary syndrome	0.0021	0.0169	CcSEcCtD
Sildenafil—Injury—Metformin—polycystic ovary syndrome	0.00208	0.0167	CcSEcCtD
Sildenafil—ABCC5—pituitary gland—polycystic ovary syndrome	0.00206	0.0141	CbGeAlD
Sildenafil—CYP3A7—endocrine gland—polycystic ovary syndrome	0.00206	0.0141	CbGeAlD
Sildenafil—ABCC5—adipose tissue—polycystic ovary syndrome	0.00205	0.0141	CbGeAlD
Sildenafil—PDE5A—adrenal gland—polycystic ovary syndrome	0.00201	0.0138	CbGeAlD
Sildenafil—Hypoglycaemia—Metformin—polycystic ovary syndrome	0.00196	0.0158	CcSEcCtD
Sildenafil—ADORA2A—endocrine gland—polycystic ovary syndrome	0.00191	0.0131	CbGeAlD
Sildenafil—Pain in extremity—Metformin—polycystic ovary syndrome	0.00191	0.0154	CcSEcCtD
Sildenafil—ABCC10—endometrium—polycystic ovary syndrome	0.0019	0.013	CbGeAlD
Sildenafil—Migraine—Metformin—polycystic ovary syndrome	0.00188	0.0151	CcSEcCtD
Sildenafil—PDE5A—female gonad—polycystic ovary syndrome	0.00187	0.0129	CbGeAlD
Sildenafil—PDE5A—vagina—polycystic ovary syndrome	0.00186	0.0128	CbGeAlD
Sildenafil—ABCC5—adrenal gland—polycystic ovary syndrome	0.00184	0.0126	CbGeAlD
Sildenafil—Liver function test abnormal—Metformin—polycystic ovary syndrome	0.00176	0.0142	CcSEcCtD
Sildenafil—ABCC10—uterus—polycystic ovary syndrome	0.00175	0.012	CbGeAlD
Sildenafil—Abdominal pain upper—Metformin—polycystic ovary syndrome	0.00174	0.0141	CcSEcCtD
Sildenafil—PDE5A—endocrine gland—polycystic ovary syndrome	0.00174	0.012	CbGeAlD
Sildenafil—Breast disorder—Metformin—polycystic ovary syndrome	0.00173	0.0139	CcSEcCtD
Sildenafil—ABCC10—pituitary gland—polycystic ovary syndrome	0.00172	0.0118	CbGeAlD
Sildenafil—ABCC5—female gonad—polycystic ovary syndrome	0.00171	0.0118	CbGeAlD
Sildenafil—ABCC10—adipose tissue—polycystic ovary syndrome	0.00171	0.0118	CbGeAlD
Sildenafil—Nasopharyngitis—Metformin—polycystic ovary syndrome	0.00171	0.0138	CcSEcCtD
Sildenafil—ABCC5—vagina—polycystic ovary syndrome	0.0017	0.0117	CbGeAlD
Sildenafil—Abdominal distension—Metformin—polycystic ovary syndrome	0.00166	0.0134	CcSEcCtD
Sildenafil—Influenza—Metformin—polycystic ovary syndrome	0.00165	0.0133	CcSEcCtD
Sildenafil—Angina pectoris—Metformin—polycystic ovary syndrome	0.00161	0.013	CcSEcCtD
Sildenafil—ABCC10—adrenal gland—polycystic ovary syndrome	0.00153	0.0105	CbGeAlD
Sildenafil—Upper respiratory tract infection—Metformin—polycystic ovary syndrome	0.00153	0.0124	CcSEcCtD
Sildenafil—Infestation—Metformin—polycystic ovary syndrome	0.00147	0.0119	CcSEcCtD
Sildenafil—Infestation NOS—Metformin—polycystic ovary syndrome	0.00147	0.0119	CcSEcCtD
Sildenafil—ABCC4—uterus—polycystic ovary syndrome	0.00145	0.00997	CbGeAlD
Sildenafil—Neuropathy peripheral—Metformin—polycystic ovary syndrome	0.00144	0.0116	CcSEcCtD
Sildenafil—ABCC10—female gonad—polycystic ovary syndrome	0.00143	0.00983	CbGeAlD
Sildenafil—ABCC10—vagina—polycystic ovary syndrome	0.00142	0.00977	CbGeAlD
Sildenafil—ABCC4—adipose tissue—polycystic ovary syndrome	0.00142	0.00975	CbGeAlD
Sildenafil—ABCC10—endocrine gland—polycystic ovary syndrome	0.00133	0.00915	CbGeAlD
Sildenafil—Rhinitis—Metformin—polycystic ovary syndrome	0.00132	0.0107	CcSEcCtD
Sildenafil—Hypoaesthesia—Metformin—polycystic ovary syndrome	0.00131	0.0106	CcSEcCtD
Sildenafil—Oedema peripheral—Metformin—polycystic ovary syndrome	0.0013	0.0105	CcSEcCtD
Sildenafil—Connective tissue disorder—Metformin—polycystic ovary syndrome	0.0013	0.0105	CcSEcCtD
Sildenafil—ABCC4—adrenal gland—polycystic ovary syndrome	0.00127	0.00875	CbGeAlD
Sildenafil—Eye disorder—Metformin—polycystic ovary syndrome	0.00123	0.00995	CcSEcCtD
Sildenafil—Flushing—Metformin—polycystic ovary syndrome	0.00123	0.00988	CcSEcCtD
Sildenafil—Cardiac disorder—Metformin—polycystic ovary syndrome	0.00123	0.00988	CcSEcCtD
Sildenafil—Angiopathy—Metformin—polycystic ovary syndrome	0.0012	0.00966	CcSEcCtD
Sildenafil—Immune system disorder—Metformin—polycystic ovary syndrome	0.00119	0.00961	CcSEcCtD
Sildenafil—Mediastinal disorder—Metformin—polycystic ovary syndrome	0.00119	0.00959	CcSEcCtD
Sildenafil—ABCC4—female gonad—polycystic ovary syndrome	0.00119	0.00816	CbGeAlD
Sildenafil—Chills—Metformin—polycystic ovary syndrome	0.00119	0.00955	CcSEcCtD
Sildenafil—Erythema—Metformin—polycystic ovary syndrome	0.00115	0.00927	CcSEcCtD
Sildenafil—Malnutrition—Metformin—polycystic ovary syndrome	0.00115	0.00927	CcSEcCtD
Sildenafil—Flatulence—Metformin—polycystic ovary syndrome	0.00113	0.00913	CcSEcCtD
Sildenafil—ABCC4—endocrine gland—polycystic ovary syndrome	0.0011	0.00759	CbGeAlD
Sildenafil—Vision blurred—Metformin—polycystic ovary syndrome	0.00108	0.00873	CcSEcCtD
Sildenafil—Tremor—Metformin—polycystic ovary syndrome	0.00108	0.00868	CcSEcCtD
Sildenafil—Ill-defined disorder—Metformin—polycystic ovary syndrome	0.00107	0.0086	CcSEcCtD
Sildenafil—Malaise—Metformin—polycystic ovary syndrome	0.00104	0.00836	CcSEcCtD
Sildenafil—Syncope—Metformin—polycystic ovary syndrome	0.00103	0.00831	CcSEcCtD
Sildenafil—Palpitations—Metformin—polycystic ovary syndrome	0.00102	0.00819	CcSEcCtD
Sildenafil—Loss of consciousness—Metformin—polycystic ovary syndrome	0.00101	0.00814	CcSEcCtD
Sildenafil—Hypertension—Metformin—polycystic ovary syndrome	0.000993	0.008	CcSEcCtD
Sildenafil—CYP2C19—vagina—polycystic ovary syndrome	0.000981	0.00674	CbGeAlD
Sildenafil—Myalgia—Metformin—polycystic ovary syndrome	0.000979	0.00789	CcSEcCtD
Sildenafil—Chest pain—Metformin—polycystic ovary syndrome	0.000979	0.00789	CcSEcCtD
Sildenafil—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.000972	0.00783	CcSEcCtD
Sildenafil—CYP1A1—uterus—polycystic ovary syndrome	0.000972	0.00668	CbGeAlD
Sildenafil—Discomfort—Metformin—polycystic ovary syndrome	0.000967	0.00779	CcSEcCtD
Sildenafil—CYP1A1—adipose tissue—polycystic ovary syndrome	0.000951	0.00654	CbGeAlD
Sildenafil—Oedema—Metformin—polycystic ovary syndrome	0.000939	0.00756	CcSEcCtD
Sildenafil—Infection—Metformin—polycystic ovary syndrome	0.000933	0.00751	CcSEcCtD
Sildenafil—CYP3A5—adipose tissue—polycystic ovary syndrome	0.00093	0.00639	CbGeAlD
Sildenafil—Shock—Metformin—polycystic ovary syndrome	0.000924	0.00744	CcSEcCtD
Sildenafil—Nervous system disorder—Metformin—polycystic ovary syndrome	0.000921	0.00742	CcSEcCtD
Sildenafil—CYP2C19—endocrine gland—polycystic ovary syndrome	0.000918	0.00631	CbGeAlD
Sildenafil—Skin disorder—Metformin—polycystic ovary syndrome	0.000912	0.00735	CcSEcCtD
Sildenafil—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.000907	0.00731	CcSEcCtD
Sildenafil—Anorexia—Metformin—polycystic ovary syndrome	0.000895	0.00721	CcSEcCtD
Sildenafil—Hypotension—Metformin—polycystic ovary syndrome	0.000877	0.00707	CcSEcCtD
Sildenafil—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.000855	0.00689	CcSEcCtD
Sildenafil—Paraesthesia—Metformin—polycystic ovary syndrome	0.000843	0.00679	CcSEcCtD
Sildenafil—Dyspnoea—Metformin—polycystic ovary syndrome	0.000837	0.00674	CcSEcCtD
Sildenafil—Somnolence—Metformin—polycystic ovary syndrome	0.000835	0.00672	CcSEcCtD
Sildenafil—Dyspepsia—Metformin—polycystic ovary syndrome	0.000826	0.00666	CcSEcCtD
Sildenafil—Decreased appetite—Metformin—polycystic ovary syndrome	0.000816	0.00657	CcSEcCtD
Sildenafil—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.00081	0.00653	CcSEcCtD
Sildenafil—Fatigue—Metformin—polycystic ovary syndrome	0.000809	0.00652	CcSEcCtD
Sildenafil—Constipation—Metformin—polycystic ovary syndrome	0.000803	0.00647	CcSEcCtD
Sildenafil—CYP1A1—female gonad—polycystic ovary syndrome	0.000795	0.00547	CbGeAlD
Sildenafil—CYP1A1—vagina—polycystic ovary syndrome	0.000791	0.00543	CbGeAlD
Sildenafil—CYP2E1—adrenal gland—polycystic ovary syndrome	0.000778	0.00535	CbGeAlD
Sildenafil—CYP3A5—female gonad—polycystic ovary syndrome	0.000778	0.00534	CbGeAlD
Sildenafil—Feeling abnormal—Metformin—polycystic ovary syndrome	0.000774	0.00623	CcSEcCtD
Sildenafil—CYP3A5—vagina—polycystic ovary syndrome	0.000773	0.00531	CbGeAlD
Sildenafil—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.000768	0.00618	CcSEcCtD
Sildenafil—Urticaria—Metformin—polycystic ovary syndrome	0.000746	0.00601	CcSEcCtD
Sildenafil—Abdominal pain—Metformin—polycystic ovary syndrome	0.000742	0.00598	CcSEcCtD
Sildenafil—CYP1A1—endocrine gland—polycystic ovary syndrome	0.00074	0.00508	CbGeAlD
Sildenafil—CYP3A5—endocrine gland—polycystic ovary syndrome	0.000723	0.00497	CbGeAlD
Sildenafil—CYP2C9—endocrine gland—polycystic ovary syndrome	0.000712	0.00489	CbGeAlD
Sildenafil—CYP2E1—endocrine gland—polycystic ovary syndrome	0.000675	0.00464	CbGeAlD
Sildenafil—Asthenia—Metformin—polycystic ovary syndrome	0.000674	0.00543	CcSEcCtD
Sildenafil—Pruritus—Metformin—polycystic ovary syndrome	0.000664	0.00535	CcSEcCtD
Sildenafil—Diarrhoea—Metformin—polycystic ovary syndrome	0.000642	0.00517	CcSEcCtD
Sildenafil—Dizziness—Metformin—polycystic ovary syndrome	0.000621	0.005	CcSEcCtD
Sildenafil—Vomiting—Metformin—polycystic ovary syndrome	0.000597	0.00481	CcSEcCtD
Sildenafil—Rash—Metformin—polycystic ovary syndrome	0.000592	0.00477	CcSEcCtD
Sildenafil—Dermatitis—Metformin—polycystic ovary syndrome	0.000591	0.00476	CcSEcCtD
Sildenafil—Headache—Metformin—polycystic ovary syndrome	0.000588	0.00474	CcSEcCtD
Sildenafil—CYP2D6—female gonad—polycystic ovary syndrome	0.000574	0.00395	CbGeAlD
Sildenafil—Nausea—Metformin—polycystic ovary syndrome	0.000558	0.00449	CcSEcCtD
Sildenafil—CYP3A4—endocrine gland—polycystic ovary syndrome	0.000543	0.00373	CbGeAlD
Sildenafil—CYP2D6—endocrine gland—polycystic ovary syndrome	0.000534	0.00367	CbGeAlD
Sildenafil—CYP3A4—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	3.37e-05	0.000196	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	3.36e-05	0.000195	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—STAR—polycystic ovary syndrome	3.35e-05	0.000195	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—AKR1C2—polycystic ovary syndrome	3.33e-05	0.000193	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—TEAD2—polycystic ovary syndrome	3.33e-05	0.000193	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—SULT2A1—polycystic ovary syndrome	3.31e-05	0.000193	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	3.31e-05	0.000193	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—AKR1C2—polycystic ovary syndrome	3.3e-05	0.000192	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—TEAD2—polycystic ovary syndrome	3.3e-05	0.000192	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—GHRL—polycystic ovary syndrome	3.3e-05	0.000192	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—PLAT—polycystic ovary syndrome	3.3e-05	0.000192	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—MTHFR—polycystic ovary syndrome	3.22e-05	0.000187	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—RRM2—polycystic ovary syndrome	3.21e-05	0.000187	CbGpPWpGaD
Sildenafil—ABCC5—Disease—IRS1—polycystic ovary syndrome	3.19e-05	0.000186	CbGpPWpGaD
Sildenafil—ADORA2A—GPCR downstream signaling—POMC—polycystic ovary syndrome	3.17e-05	0.000185	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	3.17e-05	0.000184	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—HMMR—polycystic ovary syndrome	3.17e-05	0.000184	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—HMMR—polycystic ovary syndrome	3.16e-05	0.000184	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—ATF1—polycystic ovary syndrome	3.14e-05	0.000183	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	3.12e-05	0.000182	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—YAP1—polycystic ovary syndrome	3.09e-05	0.00018	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—TCF7L2—polycystic ovary syndrome	3.07e-05	0.000178	CbGpPWpGaD
Sildenafil—ABCC5—Disease—INS—polycystic ovary syndrome	3.06e-05	0.000178	CbGpPWpGaD
Sildenafil—ADORA2A—GPCR downstream signaling—AKT2—polycystic ovary syndrome	3.05e-05	0.000177	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—PNPLA2—polycystic ovary syndrome	3.03e-05	0.000176	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—HSD3B1—polycystic ovary syndrome	3.02e-05	0.000176	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—HSD3B1—polycystic ovary syndrome	3.02e-05	0.000175	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—NMNAT3—polycystic ovary syndrome	3.01e-05	0.000175	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—HMMR—polycystic ovary syndrome	2.99e-05	0.000174	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—NAMPT—polycystic ovary syndrome	2.97e-05	0.000173	CbGpPWpGaD
Sildenafil—ABCC5—Disease—AKT2—polycystic ovary syndrome	2.96e-05	0.000172	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—CYP11A1—polycystic ovary syndrome	2.94e-05	0.000171	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—NGFR—polycystic ovary syndrome	2.9e-05	0.000169	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—POMC—polycystic ovary syndrome	2.88e-05	0.000168	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—PRL—polycystic ovary syndrome	2.88e-05	0.000167	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—SRD5A1—polycystic ovary syndrome	2.87e-05	0.000167	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—HSD3B1—polycystic ovary syndrome	2.85e-05	0.000166	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	2.82e-05	0.000164	CbGpPWpGaD
Sildenafil—ABCC5—Disease—SERPINE1—polycystic ovary syndrome	2.81e-05	0.000163	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—PNPLA2—polycystic ovary syndrome	2.79e-05	0.000162	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—AKR1C3—polycystic ovary syndrome	2.77e-05	0.000161	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—AKT2—polycystic ovary syndrome	2.77e-05	0.000161	CbGpPWpGaD
Sildenafil—ABCC4—Hemostasis—VEGFA—polycystic ovary syndrome	2.77e-05	0.000161	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—PNPLA2—polycystic ovary syndrome	2.76e-05	0.000161	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—LHB—polycystic ovary syndrome	2.76e-05	0.00016	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—LPCAT2—polycystic ovary syndrome	2.75e-05	0.00016	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—SUOX—polycystic ovary syndrome	2.75e-05	0.00016	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—LHB—polycystic ovary syndrome	2.75e-05	0.00016	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—STAR—polycystic ovary syndrome	2.74e-05	0.000159	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—CYP17A1—polycystic ovary syndrome	2.73e-05	0.000159	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—ADRB2—polycystic ovary syndrome	2.73e-05	0.000159	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	2.71e-05	0.000158	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—HSD3B2—polycystic ovary syndrome	2.69e-05	0.000157	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—HSD3B2—polycystic ovary syndrome	2.69e-05	0.000156	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—SRD5A1—polycystic ovary syndrome	2.64e-05	0.000154	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—SRD5A1—polycystic ovary syndrome	2.62e-05	0.000152	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—PPARG—polycystic ovary syndrome	2.61e-05	0.000152	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—AKR1C1—polycystic ovary syndrome	2.61e-05	0.000152	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—AKR1C1—polycystic ovary syndrome	2.6e-05	0.000151	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—LHB—polycystic ovary syndrome	2.6e-05	0.000151	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—POMC—polycystic ovary syndrome	2.58e-05	0.00015	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—INS—polycystic ovary syndrome	2.56e-05	0.000149	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—ISYNA1—polycystic ovary syndrome	2.56e-05	0.000149	CbGpPWpGaD
Sildenafil—CYP3A4—Biological oxidations—POMC—polycystic ovary syndrome	2.55e-05	0.000148	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—HSD3B2—polycystic ovary syndrome	2.54e-05	0.000148	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—GNAS—polycystic ovary syndrome	2.53e-05	0.000147	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—STAR—polycystic ovary syndrome	2.52e-05	0.000147	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—VEGFA—polycystic ovary syndrome	2.51e-05	0.000146	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—STAR—polycystic ovary syndrome	2.5e-05	0.000145	CbGpPWpGaD
Sildenafil—PDE6G—Disease—IL6—polycystic ovary syndrome	2.48e-05	0.000144	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	2.47e-05	0.000144	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—AKR1C1—polycystic ovary syndrome	2.46e-05	0.000143	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—HMMR—polycystic ovary syndrome	2.44e-05	0.000142	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—NCOR1—polycystic ovary syndrome	2.41e-05	0.00014	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—SULT2A1—polycystic ovary syndrome	2.4e-05	0.00014	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—SULT2A1—polycystic ovary syndrome	2.4e-05	0.000139	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—NRG1—polycystic ovary syndrome	2.36e-05	0.000137	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—TH—polycystic ovary syndrome	2.36e-05	0.000137	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—HSD3B1—polycystic ovary syndrome	2.33e-05	0.000136	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—RRM2—polycystic ovary syndrome	2.33e-05	0.000135	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—RRM2—polycystic ovary syndrome	2.32e-05	0.000135	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	2.3e-05	0.000134	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—SLC2A4—polycystic ovary syndrome	2.3e-05	0.000134	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—SULT2A1—polycystic ovary syndrome	2.26e-05	0.000132	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—HMMR—polycystic ovary syndrome	2.25e-05	0.000131	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—YAP1—polycystic ovary syndrome	2.24e-05	0.00013	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—YAP1—polycystic ovary syndrome	2.24e-05	0.00013	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—HMMR—polycystic ovary syndrome	2.23e-05	0.00013	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—RRM2—polycystic ovary syndrome	2.19e-05	0.000127	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	2.18e-05	0.000127	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—AKR1C2—polycystic ovary syndrome	2.18e-05	0.000126	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—TEAD2—polycystic ovary syndrome	2.18e-05	0.000126	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—CYP19A1—polycystic ovary syndrome	2.16e-05	0.000126	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—NAMPT—polycystic ovary syndrome	2.15e-05	0.000125	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—NAMPT—polycystic ovary syndrome	2.15e-05	0.000125	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—HSD3B1—polycystic ovary syndrome	2.14e-05	0.000125	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—CYP11A1—polycystic ovary syndrome	2.13e-05	0.000124	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—LHB—polycystic ovary syndrome	2.13e-05	0.000124	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—HSD3B1—polycystic ovary syndrome	2.13e-05	0.000124	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—CYP11A1—polycystic ovary syndrome	2.12e-05	0.000123	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—YAP1—polycystic ovary syndrome	2.11e-05	0.000123	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	2.1e-05	0.000122	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—HSD3B2—polycystic ovary syndrome	2.08e-05	0.000121	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—NAMPT—polycystic ovary syndrome	2.03e-05	0.000118	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—IRS2—polycystic ovary syndrome	2.03e-05	0.000118	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	2.02e-05	0.000117	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—AKR1C1—polycystic ovary syndrome	2.01e-05	0.000117	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—AKR1C3—polycystic ovary syndrome	2.01e-05	0.000117	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—CYP11A1—polycystic ovary syndrome	2e-05	0.000117	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—AKR1C3—polycystic ovary syndrome	2e-05	0.000116	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	1.99e-05	0.000116	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	1.99e-05	0.000116	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—LEP—polycystic ovary syndrome	1.98e-05	0.000115	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—CYP17A1—polycystic ovary syndrome	1.98e-05	0.000115	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—CYP17A1—polycystic ovary syndrome	1.97e-05	0.000115	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—LHB—polycystic ovary syndrome	1.96e-05	0.000114	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—LHB—polycystic ovary syndrome	1.94e-05	0.000113	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—GNAS—polycystic ovary syndrome	1.93e-05	0.000112	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—HSD3B2—polycystic ovary syndrome	1.91e-05	0.000111	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—HSD3B2—polycystic ovary syndrome	1.89e-05	0.00011	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—AKR1C3—polycystic ovary syndrome	1.89e-05	0.00011	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—CYP17A1—polycystic ovary syndrome	1.86e-05	0.000108	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—SULT2A1—polycystic ovary syndrome	1.85e-05	0.000108	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—AKR1C1—polycystic ovary syndrome	1.85e-05	0.000108	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—NCOR1—polycystic ovary syndrome	1.84e-05	0.000107	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—AKR1C1—polycystic ovary syndrome	1.84e-05	0.000107	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—PNPLA2—polycystic ovary syndrome	1.82e-05	0.000106	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—RRM2—polycystic ovary syndrome	1.79e-05	0.000104	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—IRS1—polycystic ovary syndrome	1.77e-05	0.000103	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—CYP1A1—polycystic ovary syndrome	1.74e-05	0.000101	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—IL6—polycystic ovary syndrome	1.73e-05	0.000101	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—YAP1—polycystic ovary syndrome	1.73e-05	0.000101	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	1.73e-05	0.0001	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—TH—polycystic ovary syndrome	1.71e-05	9.94e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—TH—polycystic ovary syndrome	1.71e-05	9.92e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—SULT2A1—polycystic ovary syndrome	1.7e-05	9.9e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—POMC—polycystic ovary syndrome	1.7e-05	9.9e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—INS—polycystic ovary syndrome	1.69e-05	9.84e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—SULT2A1—polycystic ovary syndrome	1.69e-05	9.82e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—SLC2A4—polycystic ovary syndrome	1.66e-05	9.67e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—NAMPT—polycystic ovary syndrome	1.66e-05	9.66e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—SLC2A4—polycystic ovary syndrome	1.66e-05	9.65e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	1.65e-05	9.6e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—RRM2—polycystic ovary syndrome	1.65e-05	9.59e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	1.65e-05	9.58e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—CYP11A1—polycystic ovary syndrome	1.64e-05	9.54e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—IGF1—polycystic ovary syndrome	1.64e-05	9.52e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—AKT2—polycystic ovary syndrome	1.64e-05	9.51e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—RRM2—polycystic ovary syndrome	1.64e-05	9.51e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	1.63e-05	9.47e-05	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—MTHFR—polycystic ovary syndrome	1.62e-05	9.43e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—TH—polycystic ovary syndrome	1.61e-05	9.37e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—YAP1—polycystic ovary syndrome	1.59e-05	9.24e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—YAP1—polycystic ovary syndrome	1.58e-05	9.16e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—SLC2A4—polycystic ovary syndrome	1.57e-05	9.12e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—CYP19A1—polycystic ovary syndrome	1.56e-05	9.09e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—CYP19A1—polycystic ovary syndrome	1.56e-05	9.07e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—SERPINE1—polycystic ovary syndrome	1.56e-05	9.04e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—AKR1C3—polycystic ovary syndrome	1.55e-05	9.01e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—NAMPT—polycystic ovary syndrome	1.53e-05	8.88e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—CYP17A1—polycystic ovary syndrome	1.53e-05	8.87e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—NAMPT—polycystic ovary syndrome	1.51e-05	8.8e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—CYP11A1—polycystic ovary syndrome	1.51e-05	8.77e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	1.51e-05	8.75e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—CYP11A1—polycystic ovary syndrome	1.5e-05	8.7e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	1.49e-05	8.63e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—CYP19A1—polycystic ovary syndrome	1.48e-05	8.57e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	1.47e-05	8.54e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—AKR1C3—polycystic ovary syndrome	1.43e-05	8.28e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—AKR1C3—polycystic ovary syndrome	1.41e-05	8.21e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—CYP17A1—polycystic ovary syndrome	1.4e-05	8.15e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	1.4e-05	8.15e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—GNAS—polycystic ovary syndrome	1.4e-05	8.12e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—GNAS—polycystic ovary syndrome	1.39e-05	8.1e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—CYP17A1—polycystic ovary syndrome	1.39e-05	8.08e-05	CbGpPWpGaD
Sildenafil—ABCC5—Disease—IL6—polycystic ovary syndrome	1.34e-05	7.77e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—NCOR1—polycystic ovary syndrome	1.33e-05	7.73e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—NCOR1—polycystic ovary syndrome	1.33e-05	7.72e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—TH—polycystic ovary syndrome	1.32e-05	7.67e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—GNAS—polycystic ovary syndrome	1.32e-05	7.65e-05	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—PPARG—polycystic ovary syndrome	1.32e-05	7.65e-05	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—POMC—polycystic ovary syndrome	1.3e-05	7.54e-05	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—INS—polycystic ovary syndrome	1.29e-05	7.5e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—SLC2A4—polycystic ovary syndrome	1.28e-05	7.46e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	1.28e-05	7.43e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—CYP1A1—polycystic ovary syndrome	1.26e-05	7.33e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—CYP1A1—polycystic ovary syndrome	1.26e-05	7.31e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—NCOR1—polycystic ovary syndrome	1.25e-05	7.29e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—IL6—polycystic ovary syndrome	1.25e-05	7.28e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	1.25e-05	7.26e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—TH—polycystic ovary syndrome	1.21e-05	7.06e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	1.21e-05	7.03e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—CYP19A1—polycystic ovary syndrome	1.21e-05	7.02e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—TH—polycystic ovary syndrome	1.2e-05	6.99e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—SLC2A4—polycystic ovary syndrome	1.18e-05	6.86e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—MTHFR—polycystic ovary syndrome	1.18e-05	6.83e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—MTHFR—polycystic ovary syndrome	1.17e-05	6.82e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—SLC2A4—polycystic ovary syndrome	1.17e-05	6.8e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	1.11e-05	6.47e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—CYP19A1—polycystic ovary syndrome	1.11e-05	6.45e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—MTHFR—polycystic ovary syndrome	1.11e-05	6.44e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—CYP19A1—polycystic ovary syndrome	1.1e-05	6.4e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	1.08e-05	6.27e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—GNAS—polycystic ovary syndrome	1.08e-05	6.26e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.07e-05	6.22e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	1.04e-05	6.04e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—NCOR1—polycystic ovary syndrome	1.03e-05	5.97e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	9.99e-06	5.81e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—GNAS—polycystic ovary syndrome	9.91e-06	5.76e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	9.87e-06	5.73e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—GNAS—polycystic ovary syndrome	9.82e-06	5.71e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—CYP1A1—polycystic ovary syndrome	9.73e-06	5.66e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—PPARG—polycystic ovary syndrome	9.53e-06	5.54e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—PPARG—polycystic ovary syndrome	9.51e-06	5.53e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—NCOR1—polycystic ovary syndrome	9.44e-06	5.49e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—POMC—polycystic ovary syndrome	9.4e-06	5.47e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—POMC—polycystic ovary syndrome	9.38e-06	5.45e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—NCOR1—polycystic ovary syndrome	9.36e-06	5.44e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—INS—polycystic ovary syndrome	9.35e-06	5.43e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—INS—polycystic ovary syndrome	9.33e-06	5.42e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	9.32e-06	5.42e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	9.17e-06	5.33e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—MTHFR—polycystic ovary syndrome	9.07e-06	5.27e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—PPARG—polycystic ovary syndrome	8.99e-06	5.22e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—CYP1A1—polycystic ovary syndrome	8.95e-06	5.2e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—CYP1A1—polycystic ovary syndrome	8.87e-06	5.16e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—POMC—polycystic ovary syndrome	8.86e-06	5.15e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—INS—polycystic ovary syndrome	8.82e-06	5.12e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—MTHFR—polycystic ovary syndrome	8.34e-06	4.85e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—MTHFR—polycystic ovary syndrome	8.27e-06	4.81e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—TH—polycystic ovary syndrome	7.94e-06	4.61e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	7.72e-06	4.49e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—IL6—polycystic ovary syndrome	7.4e-06	4.3e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—PPARG—polycystic ovary syndrome	7.36e-06	4.28e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	7.26e-06	4.22e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—POMC—polycystic ovary syndrome	7.25e-06	4.22e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—INS—polycystic ovary syndrome	7.21e-06	4.19e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—PPARG—polycystic ovary syndrome	6.77e-06	3.93e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—PPARG—polycystic ovary syndrome	6.71e-06	3.9e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—POMC—polycystic ovary syndrome	6.67e-06	3.88e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—INS—polycystic ovary syndrome	6.64e-06	3.86e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—POMC—polycystic ovary syndrome	6.61e-06	3.84e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—INS—polycystic ovary syndrome	6.58e-06	3.82e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	6.48e-06	3.77e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	6.17e-06	3.59e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	5.85e-06	3.4e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	5.45e-06	3.17e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	4.42e-06	2.57e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	4.36e-06	2.54e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—INS—polycystic ovary syndrome	4.34e-06	2.52e-05	CbGpPWpGaD
